A122 finally came out earlier this week. I hope no one was holding his/her breath on BBC coverage because, as expected, few of the big media reported its findings. Despite not being press released by Cochrane and not being twinned to an editorial, it got incredibly high coverage in the twittosphere.
The Altmetric (a broad measure of the general interest…
Keep reading with a 7-day free trial
Subscribe to Trust the Evidence to keep reading this post and get 7 days of free access to the full post archives.